RESILIENCE helps you survive cancer with a strong heart

News

RESILIENCE clinical trial

Our RESILIENCE team has prepared this video in which we explain how the therapy is randomized for the RESILIENCE clinical trial. For this procedure, we will use the electronic case report form (e-CRF), a software that will assign one of the corresponding therapies randomly. The research team will access to

More »

RESILIENCE TALKS – Leaders of the Future

Interview with Alberto López-García – Fundación Jiménez Díaz University Hospital (IIS-FJD) Alberto is a young researcher leading an important part of the project. Alberto represents the young community of the project. One of the goals of RESILIENCE is to identify the European leaders of the future. Could you tell us

More »

CNIC coordina RESILIENCE, un proyecto diseñado para reducir la insuficiencia cardíaca en pacientes con cancer

La Comisión Europea, a través del programa H2020 “Salud, Cambio Demográfico y Bienestar”, ha designado al Centro Nacional de Investigaciones Cardiovasculares (CNIC) como coordinador de RESILIENCE (REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs), un ambicioso proyecto especialmente diseñado para desarrollar una nueva intervención médica destinada a reducir la prevalencia

More »

RESILIENCE, a project to reduce the prevalence of heart failure in cancer survivors

Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects. Every year, more than 3 million Europeans receive aCancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse

More »

Newsletter

Subscribe to our Newsletter

RESILIENCE

On the press

Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions